Pacira BioSciences, Inc.

PCRX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
DEFA14A May 5, 2026 DEFA14A
SCHEDULE 13G May 1, 2026
SCHEDULE 13G May 1, 2026
10-Q Apr 30, 2026 10-K - PCRX - 03.31.2026
8-K Apr 30, 2026 8-K
PRRN14A Apr 30, 2026
DEFA14A Apr 28, 2026 DEFA14A
ARS Apr 28, 2026 ARS
DEFC14A Apr 28, 2026 FORM DEFC14A
4 Apr 24, 2026 FORM 4
144 Apr 23, 2026
4 Apr 22, 2026 FORM 4
144 Apr 22, 2026
144 Apr 21, 2026
144 Apr 20, 2026
PREC14A Apr 17, 2026 FORM- PREC14A
SCHEDULE 13G Apr 9, 2026
SCHEDULE 13G/A Mar 27, 2026
4/A Mar 19, 2026 FORM 4/A
4 Mar 19, 2026 FORM 4
4 Mar 19, 2026 FORM 4
144 Mar 17, 2026
144 Mar 17, 2026
SCHEDULE 13D/A Mar 12, 2026
DFAN14A Mar 12, 2026
← Newer Page 3 of 53 · 1302 filings Older →